BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25890693)

  • 1. Relationship between neurocognition and functional recovery in first-episode schizophrenia: Results from the second year of the Oslo multi-follow-up study.
    Torgalsbøen AK; Mohn C; Czajkowski N; Rund BR
    Psychiatry Res; 2015 Jun; 227(2-3):185-91. PubMed ID: 25890693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
    Fu S; Czajkowski N; Torgalsbøen AK
    Psychiatry Res; 2018 Sep; 267():319-326. PubMed ID: 29957548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia.
    Torgalsbøen AK; Mohn C; Rishovd Rund B
    Psychiatry Res; 2014 Apr; 216(1):1-5. PubMed ID: 24530159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia.
    Fu S; Czajkowski N; Rund BR; Torgalsbøen AK
    Schizophr Res; 2017 Dec; 190():144-149. PubMed ID: 28302394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study.
    Addington J; Addington D
    Schizophr Res; 2000 Jul; 44(1):47-56. PubMed ID: 10867311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.
    O'Reilly K; Donohoe G; Coyle C; O'Sullivan D; Rowe A; Losty M; McDonagh T; McGuinness L; Ennis Y; Watts E; Brennan L; Owens E; Davoren M; Mullaney R; Abidin Z; Kennedy HG
    BMC Psychiatry; 2015 Jul; 15():155. PubMed ID: 26159728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological profile in adult schizophrenia measured with the CMINDS.
    van Erp TG; Preda A; Turner JA; Callahan S; Calhoun VD; Bustillo JR; Lim KO; Mueller B; Brown GG; Vaidya JG; McEwen S; Belger A; Voyvodic J; Mathalon DH; Nguyen D; Ford JM; Potkin SG;
    Psychiatry Res; 2015 Dec; 230(3):826-34. PubMed ID: 26586142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Norwegian standardization of the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery.
    Mohn C; Sundet K; Rund BR
    J Clin Exp Neuropsychol; 2012; 34(6):667-77. PubMed ID: 22439943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.
    Jordan G; Lutgens D; Joober R; Lepage M; Iyer SN; Malla A
    J Clin Psychiatry; 2014 Jun; 75(6):e566-72. PubMed ID: 25004197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.
    Ventura J; Welikson T; Ered A; Subotnik KL; Keefe RSE; Hellemann GS; Nuechterlein KH
    Early Interv Psychiatry; 2020 Feb; 14(1):106-114. PubMed ID: 31183960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery.
    Williams LM; Whitford TJ; Flynn G; Wong W; Liddell BJ; Silverstein S; Galletly C; Harris AW; Gordon E
    Schizophr Res; 2008 Feb; 99(1-3):182-91. PubMed ID: 18053688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.
    Lystad JU; Falkum E; Mohn C; Haaland VØ; Bull H; Evensen S; Rund BR; Ueland T
    Psychiatry Res; 2014 Dec; 220(3):1094-101. PubMed ID: 25242432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognition and recovery in first episode psychosis.
    Faber G; Smid HG; Van Gool AR; Wunderink L; Wiersma D; van den Bosch RJ
    Psychiatry Res; 2011 Jun; 188(1):1-6. PubMed ID: 21122926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.
    Rund BR; Barder HE; Evensen J; Haahr U; ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld J; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Simonsen E; Sundet K; Vaglum P; McGlashan T; Friis S
    Schizophr Bull; 2016 Jan; 42(1):87-95. PubMed ID: 26101305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.